Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
[18F]MODAG-009 in Multiple System Atrophy: NCT07640555 Clinical Landscape Report 2026
9 min read
[18F]MODAG-009 in Multiple System Atrophy: NCT07640555 Clinical Landscape Report 2026
18 September 2026
NCT07640555 clinical landscape for Multiple System Atrophy: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Benzgalantamine Gluconate in Alzheimer Disease: NCT07633470 Clinical Landscape Report 2026
9 min read
Benzgalantamine Gluconate in Alzheimer Disease: NCT07633470 Clinical Landscape Report 2026
18 September 2026
NCT07633470 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
[11C]MODAG 005 in Multiple System Atrophy: NCT07640542 Clinical Landscape Report 2026
9 min read
[11C]MODAG 005 in Multiple System Atrophy: NCT07640542 Clinical Landscape Report 2026
18 September 2026
NCT07640542 clinical landscape for Multiple System Atrophy: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma: NCT07640295 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma: NCT07640295 Clinical Landscape Report 2026
18 September 2026
NCT07640295 clinical landscape for Metastatic Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
Read →
Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) in Pulmonary Disease, Chronic Obstructive: NCT07640841 Clinical Landscape Report 2026
9 min read
Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) in Pulmonary Disease, Chronic Obstructive: NCT07640841 Clinical Landscape Report 2026
18 September 2026
NCT07640841 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Doxorubicin Hydrochloride in Ovarian Cancer: NCT07648940 Clinical Landscape Report 2026
9 min read
Doxorubicin Hydrochloride in Ovarian Cancer: NCT07648940 Clinical Landscape Report 2026
18 September 2026
NCT07648940 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
[68Ga]Ga-HT547 in Breast Cancer: NCT07639970 Clinical Landscape Report 2026
9 min read
[68Ga]Ga-HT547 in Breast Cancer: NCT07639970 Clinical Landscape Report 2026
18 September 2026
NCT07639970 clinical landscape for Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SiRNA-PD-1/PD-L1(Alexandria University) in Advanced Pancreatic Adenocarcinoma: NCT07637786 Clinical Landscape Report 2026
9 min read
SiRNA-PD-1/PD-L1(Alexandria University) in Advanced Pancreatic Adenocarcinoma: NCT07637786 Clinical Landscape Report 2026
18 September 2026
NCT07637786 clinical landscape for Advanced Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
Read →
Samuraciclib hydrochloride in Advanced Pancreatic Ductal Adenocarcinoma: NCT07645651 Clinical Landscape Report 2026
9 min read
Samuraciclib hydrochloride in Advanced Pancreatic Ductal Adenocarcinoma: NCT07645651 Clinical Landscape Report 2026
18 September 2026
NCT07645651 clinical landscape for Advanced Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →
Levodopa hydrate in Parkinson Disease: NCT07647913 Clinical Landscape Report 2026
9 min read
Levodopa hydrate in Parkinson Disease: NCT07647913 Clinical Landscape Report 2026
18 September 2026
NCT07647913 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nolgileucel in Recurrent ovarian cancer: NCT07651124 Clinical Landscape Report 2026
9 min read
Nolgileucel in Recurrent ovarian cancer: NCT07651124 Clinical Landscape Report 2026
18 September 2026
NCT07651124 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CLSP-5282 in Locally Advanced Malignant Solid Neoplasm: NCT07650357 Clinical Landscape Report 2026
9 min read
CLSP-5282 in Locally Advanced Malignant Solid Neoplasm: NCT07650357 Clinical Landscape Report 2026
18 September 2026
NCT07650357 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →